Rui Li

Guanxin V protects against ventricular remodeling after acute myocardial infarction through the interaction of TGF-β1 and Vimentin.

Bo Liang, Ning Gu, Xiaoxiao Zhang, 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Effect of renal denervation on long-term outcomes in patients with resistant hypertension

Bo Liang, Yi-ren Liang, Rui Li, 2021, Cardiovascular Diabetology.

Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism

P. Zhang, Bo Liang, Rui Li, 2022, Journal of Cardiovascular Translational Research.

Guanxin V alleviates acute myocardial infarction by restraining oxidative stress damage, apoptosis, and fibrosis through the TGF-β1 signalling pathway.

Yong Zhu, Bo Liang, Xiaoxiao Zhang, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Tongue diagnostic parameters-based diagnostic signature in coronary artery disease patients with clopidogrel resistance after percutaneous coronary intervention.

Bo Liang, Jia Lu, Rui Li, 2022, Explore.

TQ-B3203, a potent proliferation inhibitor derived from camptothecin

X. Tian, Hongjian Xu, N. Gu, 2017, Medicinal Chemistry Research.

Identification, characterization, and synthesis of process-related impurities in antiproliferative agent TQ-B3203

X. Tian, Hongjian Xu, N. Gu, 2016 .

Bioimpedance Vector Analysis for Heart Failure: Should We Put It on the Agenda?

Bo Liang, Rui Li, N. Gu, 2021, Frontiers in Cardiovascular Medicine.

Integrating systematic pharmacology-based strategy and experimental validation to explore the synergistic pharmacological mechanisms of Guanxin V in treating ventricular remodeling.

Bo Liang, Yi-ren Liang, Rui Li, 2021, Bioorganic chemistry.

Guanxin V Acts as an Antioxidant in Ventricular Remodeling

Yitao Liang, Bo Liang, Rui Li, 2022, Frontiers in Cardiovascular Medicine.